Skip to main content

Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap

Geissler, Jan, Bettina Ryll, Susanna Leto di Priolo, and Mary Uhlenhopp. "Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap." Therapeutic Innovation & Regulatory Science 51, no. 5 (2017/09/01 2017): 612-19. https://doi.org/10.1177/2168479017706405.

Abstract:

The value of patient involvement (PI) in medicines research and development (R&D) is increasingly recognized by all health stakeholders. Despite numerous ongoing PI initiatives, PI so far lacks structure and consistency in approach. Limited formal documentation of PI activities further hampers the sharing of experience and learnings, preventing timely and systematic implementation. This article summarizes the outcomes of several multistakeholder discussions during 2013-2016 in a practical roadmap for PI in medicines R&D. The roadmap highlights specific opportunities for PI along the 4 key stages of the medicines R&D life cycle and is illustrated with concrete examples. This roadmap’s aim is to provide a tool to facilitate PI during medicines research and development and is being shared to encourage implementation and further refinement.

 

¿Le pareció útil el contenido de esta página? Envianos tus comentarios
-
Your feedback helps us keep EuroGCT online. Please can you take 30 seconds to answer these quick questions?
How would you rate your experience using EuroGCT.org today?
Poor
Great
Is the information on this website understandable?
Not at all understandable
Very understandable
Is the information on this website useful?
Not at all useful
Very useful
Is the website easy to use and navigate?
Not at all easy
Very easy
Why are you interested in gene and cell therapies and research?
CAPTCHA
Esta pregunta es para comprobar si usted es un visitante humano y prevenir envíos de spam automatizado.